lovastatin has been researched along with Glomerulonephritis, Membranous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, P; Muñoz Díaz, AB | 1 |
| Byrne, MJ; Rayner, BL; van Zyl Smit, R | 1 |
| Breiteneder-Geleff, S; Haas, M; Holzer, H; Hörl, WH; Kerjaschki, D; Kramar, R; Mayer, G; Neuweiler, J; Neyer, U; Ratschek, M; Regele, HM; Schneider, B; Wirnsberger, G | 1 |
| Costa, C; Guarini, G; Vitaliano, E | 1 |
1 trial(s) available for lovastatin and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Combined Modality Therapy; Enzyme Inhibitors; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nephrotic Syndrome; Prospective Studies; Serum Albumin; Simvastatin; Time Factors | 1996 |
3 other study(ies) available for lovastatin and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil | 2004 |
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Topics: Adult; Anticholesteremic Agents; Antioxidants; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Humans; Kidney Function Tests; Lipid Peroxidation; Lovastatin; Male; Middle Aged; Probucol; Prospective Studies; Proteinuria; Treatment Outcome | 2002 |
[Lovastatin in hyperlipemia of the nephrotic syndrome].
Topics: Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Hyperlipoproteinemia Type II; Lovastatin | 1988 |